Previous close | 7.68 |
Open | 7.68 |
Bid | 6.20 |
Ask | 7.90 |
Strike | 35.00 |
Expiry date | 2024-11-15 |
Day's range | 7.68 - 7.68 |
Contract range | N/A |
Volume | |
Open interest | 653 |
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $42.19, denoting a -0.09% change from the preceding trading day.
Bristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted treatment option for adult patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer.